Research progress on platelet function testing and its application in a variety of diseases

doi:10.3969/j.issn.1673-8640.2015.01.018

Abstract

Abstract:

Abnormal platelet quantity and quality are important factors leading to bleeding and thrombotic diseases. Meanwhile, they are also involved in the pathological process of some diseases, such as diabetic complications, angiocardiopathy, tumor and inflammatory. Platelet function testing, particularly for aggregation function and activation function of platelets, can provide a approach for the prevention and diagnosis of clinical diseases, especially for the treatment and monitoring of diseases.

Key words: Platelet function testing, Diabetes mellitus, Antithrombotic therapy

CLC Number:

R446.11

CAI Yuchan, LI Zhi.. Research progress on platelet function testing and its application in a variety of diseases[J]. Laboratory Medicine, 2015, 30(1): 72-75.

References 36

[1]	FURIE B, FURIE BC.Mechanisms of thrombus formation[J]. N Engl J Med, 2008, 359(9): 938-949.
[2]	FROSSARD M, FUCHS I, LEITNER JM, et al.Platelet function predicts myocardial damage in patients with acute myocardial infarction[J].Circulation, 2004, 110(11): 1392-1397.
[3]	MICHELSON AD.Platelet function testing in cardiov-ascular diseases[J]. Circulation, 2004, 110(19): e489-e493.
[4]	李晶华, 李智, 王吉影, 等. 2型糖尿病患者血小板-白细胞聚集体和血小板活化指标的研究[J].中华检验医学杂志, 2012, 35(10): 940-944.
[5]	ELALAMY I, CHAKROUN T, GEROTZIAFAS GT, et al.Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients[J].Thromb Res, 2008, 121(6): 843-848.
[6]	RIEGER S, ENDLER G, MANNHALTER C, et al.To: Tschoepe D, Menart B, Ferber P, et al. (2003) Genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with type 2 diabetes mellitus[J].Diabetologia, 2004, 47(4): 761-762.
[7]	LPEZ E, BERNA-ERRO A, HERNNDEZ-CRUZ JM, et al. Immunophilins are involved in the altered platelet aggregation observed in patients with type 2 diabetes mellitus[J].Curr Med Chem, 2013, 20(14): 1912-1921.
[8]	叶山东,李素梅,莫蔚林,等. 糖尿病合并白蛋白尿患者血小板聚集功能和膜蛋白表达的变化[J].中国糖尿病杂志, 2001,9(4): 207-209.
[9]	邓艳,张朝典. 糖尿病患者血液流变学、血小板聚集功能及血脂检测的意义[J].内科急危重症杂志, 2007,13(6): 306-307.
[10]	KONSTANTOPOULOS K, NEELAMEGHAM S, BURNS AR, et al.Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin[J].Circulation, 1998, 98(9): 873-882.
[11]	饶绘, 赵惠, 李彬, 等. PCI术前测定血小板表面P-选择素的意义[J].检验医学, 2012, 27(1): 12-14.
[12]	LIEVENS D, ZERNECKE A, SEIJKENS T, et al.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis[J].Blood, 2010, 116(20): 4317-4327.
[13]	FRANKS ZG, CAMPBELL RA, WEYRICH AS, et al.Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke[J].Ann N Y Acad Sci, 2010, 1207: 11-17.
[14]	GLASS CK, WITZTUM JL.Atherosclerosis, the road ahead[J].Cell, 2001, 104(4): 503-516.
[15]	KOYAMA H, MAENO T, FUKUMOTo S, et al.Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans[J]. Circulation, 2003, 108(5): 524-529.
[16]	SHOJI T, KOYAMA H, FUKUMOTO S, et al.Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis[J]. Atherosclerosis, 2006, 188(1): 190-195.
[17]	HTUN P, FATEH-MOGHADAM S, TOMANDL B, et al.Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia[J]. Stroke, 2006, 37(9): 2283-2287.
[18]	Habazettl H, Hanusch P,Kupatt C. Effects of endothelium/leukocytes/platelet interaction on myocardial ischemia--reperfusion injury[J].Z Kardiol, 2000, 89(Suppl 9): IX/92-IX/95.
[19]	WANG Y, ZHANG H.Platelet-induced inhibition of tumor cell growth[J].Thromb Res, 2008, 123(2): 324-330.
[20]	CHO MS, BOTTSFORD-MILLER J, VASQUEZ HG.Platelets increase the proliferation of ovarian cancer cells[J].Blood, 2012, 120(24): 4869-4872.
[21]	NIESWANDT B, HAFNER M, ECHTENACHER B, et al.Lysis of tumor cells by natural killer cells in mice is impeded by platelets[J].Cancer Res, 1999, 59(6): 1295-1300.
[22]	SCHUMACHER D, STRILIC B, SIVARAJ KK.Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor[J].Cancer Cell, 2013, 24(1): 130-137.
[23]	GAY LJ, FELDING-HABERMANN B.Contribution of platelets to tumour metastasis[J].Nat Rev Cancer, 2011, 11(2): 123-134.
[24]	WANG Y, SUN Y, LI D, et al.Platelet P2Y12 is involved in murine pulmonary metastasis[J].PLoS One, 2013, 8(11): e80780.
[25]	包文鑫, 李佳增,陈炳献. 比浊法测定血小板聚集性[J].中华血液学杂志, 1980, 1(4): 225-228.
[26]	SIERKO E, WOJTUKIEWICZ MZ.Platelets and angiogenesis in malignancy[J].Semin Thromb Hemost, 2004, 30(1): 95-108.
[27]	BATTINELLI EM, MARKENS BA, ITALIANO JE JR.Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis[J]. Blood, 2011, 118(5): 1359-1369.
[28]	KHORANA AA, KUDERER NM, CULAKOVA E, et al.Development and validation of a predictive model for chemotherapy-associated thrombosis[J].Blood, 2008, 111(10): 4902-4907.
[29]	AY C, SIMANEK R, VORMITTAG R.High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)[J].Blood, 2008, 112(7): 2703-2708.
[30]	黄智勇, 曾国琼, 谭旭东, 等. 血小板激活与活动期发生溃疡性结肠炎的关系[J].中国基层医药, 2006, 13(3): 386-387.
[31]	CARTY E, MACEY M, MCCARTNEY SA, et al.Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist:anti-inflammatory profile in inflammatory bowel disease[J].Aliment Pharmacol Ther, 2000, 14(6): 807-817.
[32]	OSTROWSKI SR, BERG RM, WINDELØV NA, et al. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers[J].PLoS One, 2013, 8(3): e59368.
[33]	冷承慧. 92例脓毒症患者血小板计数动态变化的临床分析[J].河南科技大学学报(医学版), 2012, 30(2): 130-131.
[34]	乔蕊,张捷. 抗血小板药物治疗监测的进展[J].检验医学, 2013, 28(5): 442-447.
[35]	董静懿,李培成. 冠心病患者血小板CD62p及Gp Ⅱb/Ⅲa的变化[J].检验医学, 2005, 20(3): 189-191.
[36]	凌利芬, 朱新建, 王海, 等. 采血后不同时间内检测血小板聚集功能分析[J].国际检验医学杂志, 2010, 31(10): 1099-1100.